An MTF2-containing subcomplex of Polycomb Repressive Complex 2 promotes cell cycle progression through repression of D-type cyclin expression in certain cellular contexts.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...